Gemtuzumab is a monoclonal IgG4-kappa antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin.
Purity:
99.0%
CAS Number:
[220578-59-6]
Target:
Immunology/Inflammation
* VAT and and shipping costs not included. Errors and price changes excepted